Dr. Countouriotis is the President and Chief Executive Officer and a member of the Board of Directors of Turning Point Therapeutics. View . Av. Software applications, cybersecurity, and blockchain research are among the companys crypto and blockchain-related services. The unicorn is a digital product content distribution platform. Helen Wei - Associate Director. Biosta.. - Acerta Pharma - ZoomInfo It paid US$2.5 billion upfront and an additional US$1.5 billion after the medication passed further tests. Adyen helps organisations reach their goals faster by combining end-to-end payment capabilities, data-driven insights, and financial products into a single global solution. As a key Executive Leader he has been directly involved in the processes of growing up Acerta Pharma from 3 employees to 120 employees, increase company valuation from $2 million to $4 billion, acquire 2 compounds from big Pharma, and raise +$500 million in capital from investor Communities. Dr. Weiser is the Founder and a Principal of Actin Biomed LLC, a healthcare investment firm focused on the discovery and development of novel treatments for unmet medical needs. More than 100,000 people have joined the Elasticsearch meetup community. Mr. Rothbaum began his career at The Carson Group, a strategic consulting firm, where he managed its life sciences practice and boutique investment bank Evolution Capital. AcertaPharma - Contacts, Employees, Board Members, Advisors & Alumni Prior to joining Kartos, he was the program lead for rovalpituzumab tesirine at Stemcentrx, prior to its acquisition by AbbVie. Personalize which data points you want to see and create visualizations instantly. In 2016, Mr. Rothbaum also co-founded Kartos Therapeutics following the in-license of an investigational MDM2 inhibitor from Amgen. It focuses on the development of small molecule BTK inhibitors for cancer treatment. Elastic is a search startup that specialises in self-managed and SaaS solutions for search, logging, security, observability, and analytics. Adyen Issuing, a virtual and physical card-issuing firm, was founded the same year to supplement merchant payments services. Dr. Krejsa has led early- and late-phase nonclinical and clinical translation programs for diverse small molecule and protein therapeutics in oncology, autoimmune and allergy indications. Kartos Therapeutics, Inc. All rights reserved. CBI websites generally use certain cookies to enable better interactions with our sites and services. General (Ret.) The unicorn startup has stated that it is planning an initial public offering. Acerta is a leader in the field of covalent binding technology and is applying this technology to create novel selective therapies intended for the treatment of cancer and autoimmune diseases. The Netherlands has catapulted itself to the top of the European startup leaderboards, and it is identified as one of the worlds most interconnected economies as well as the fourth-best European country for startup movement, thanks to a holy trinity of a globally competitive talent pool, an abundance of incubator programmes, and a booming tech sector. Acerta Pharma Company Profile | Management and Employees List - Datanyze Acerta Pharma is part of the Manufacturing industry, and located in California, United States. Prior to Calistoga, Dr. Ulrich was Senior Scientific Director with Merck Research Laboratories/Rosetta Inpharmatics, Director of Regulatory Toxicology, Safety Pharmacology, Genetic Toxicology, Cellular and Molecular Toxicology, Microscopy and Microanalysis at Abbott Laboratories, and a Senior Scientist with The Upjohn Company and Pharmacia & Upjohn Inc. Dr. Ulrich holds several patents and has authored more than 125 publications.